Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Importation’s Appeal For Sen. Obama Wanes As Safety Concerns Rise

Executive Summary

Democratic presidential candidate Barack Obama appears to be moving away from making drug importation a main component of his health care agenda if he is elected

You may also be interested in...



A down payment on Rx importation?

The budget outline released by the Obama administration Feb. 26 "supports" FDA's "new efforts to allow Americans to buy safe and effective drugs from other countries." It is one of only three agenda items for the agency in the budget - the others are follow-on biologics and product safety - and there are no details on the cost of the efforts. In a background briefing, an official with the White House Office of Management and Budget explained the funding will "begin to lay the basis for safe and effective reimportation at FDA. But we think we need to put some infrastructure and build some processes there to do that." While Obama made importation a campaign plank, interest in it cooled as drug safety concerns heated up (1"The Pink Sheet," Oct. 20, 2008, p. 14)

A down payment on Rx importation?

The budget outline released by the Obama administration Feb. 26 "supports" FDA's "new efforts to allow Americans to buy safe and effective drugs from other countries." It is one of only three agenda items for the agency in the budget - the others are follow-on biologics and product safety - and there are no details on the cost of the efforts. In a background briefing, an official with the White House Office of Management and Budget explained the funding will "begin to lay the basis for safe and effective reimportation at FDA. But we think we need to put some infrastructure and build some processes there to do that." While Obama made importation a campaign plank, interest in it cooled as drug safety concerns heated up (1"The Pink Sheet," Oct. 20, 2008, p. 14)

McCain Demand-Side Approach to Health Costs Threatens Drug Sales Growth

The proposal by Republican presidential nominee John McCain to eliminate the income tax deduction for employer-based insurance threatens to reduce total U.S. drug expenditures by about 3 percent to 4 percent per year, according to estimates by the Boston Consulting Group

UsernamePublicRestriction

Register

LL1135645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel